Login / Signup
Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment.
Markus Hoffmann
Yeonhwa Jin
Stefan H Pöhlmann
Published in:
Cell research (2022)
Keyphrases
</>
coronavirus disease
sars cov
replacement therapy